Further Decision Processed by IB
10/24/2025
Back to search
Official data from USPTO
SPARINGVISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SPARINGVISION
ST13
US500000079205582Class
5
Filing
79205582
Registration
5393466
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/25/2025
Trademark type
Word
Nice classes
5
Filing date
01/18/2017
Registration date
02/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2024
Last transaction
10/25/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
SEVERSON,JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SPARINGVISION
Representatives
Mark Lebow Ladas & Parry
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of ocular disorders and ophthalmologic diseases and blindness prescribed and provided by ophthalmologistseye surgeonsoptometrists; medical preparations for the treatment of ophthalmologic diseases and conditions; veterinary preparations for the treatment of ophthalmologic diseases and conditions; medicines for the treatment of ocular disorders and ophthalmologic diseases; sanitary products for medical purposessanitary sterilizing preparations; dietetic substances in the nature of sugar substitutes and dietetic foods all adapted for medical use; food supplements for human beings; plastersmaterials for dressingssurgical and medical dressings; material for dental fillings and dental impressions; disinfectants
Publications
History of USPTO decisions and trademark events.
32 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/28/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
08/28/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
08/28/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/23/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/25/2024
C71T
CANCELLED SECTION 71
08/23/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/10/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/19/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/29/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/15/2018
FIMP
FINAL DISPOSITION PROCESSED
05/15/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2017
PUBO
PUBLISHED FOR OPPOSITION
11/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2017
RFNT
REFUSAL PROCESSED BY IB
05/20/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2017
RFRR
REFUSAL PROCESSED BY MPU
05/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/04/2017
CNRT
NON-FINAL ACTION WRITTEN
05/03/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2017
DOCK
ASSIGNED TO EXAMINER
04/27/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/21/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/20/2017
Continuous trademark protection
Get notified about every new filing that threatens SPARINGVISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.